Cargando…
Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 Update
Hepatocellular carcinoma (HCC) represents a significant contributor to cancer-related morbidity and mortality with increasing incidence in both developing and developed countries. Embolotherapy as a locoregional therapeutic strategy consists of trans-arterial or “bland” embolization (TAE), trans-art...
Autores principales: | Kishore, Sirish A., Bajwa, Raazi, Madoff, David C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226474/ https://www.ncbi.nlm.nih.gov/pubmed/32224882 http://dx.doi.org/10.3390/cancers12040791 |
Ejemplares similares
-
Exosome in Hepatocellular Carcinoma: an update
por: Chen, Wei, et al.
Publicado: (2021) -
Immunotherapy Updates in Advanced Hepatocellular Carcinoma
por: Singh, Amisha, et al.
Publicado: (2021) -
Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update
por: Roßner, Florian, et al.
Publicado: (2023) -
Genetic alterations in hepatocellular carcinoma: An update
por: Niu, Zhao-Shan, et al.
Publicado: (2016) -
Update on Glycosphingolipids Abundance in Hepatocellular Carcinoma
por: Byrne, Frances L., et al.
Publicado: (2022)